During the past decade, Wits Reproductive Health and HIV Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wits Reproductive Health and HIV Institute" #1 sponsor was "Microbicide Trials Network" with 2 trials, followed by "RTI International" with 2 trials sponsored, "University of Washington" with 2 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Global Antibiotics Research and Development Partnership" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wits Reproductive Health and HIV Institute" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "Wits Reproductive Health and HIV Institute" with 4 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 3 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator and "United States Agency for International Development (USAID)" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Wits Reproductive Health and HIV Institute" are "HIV Infections" (3 trials), "HIV/AIDS" (2 trials), "Acceptability" (1 trials), "Antiretroviral Therapy" (1 trials) and "Cell Phone" (1 trials). Many other conditions were trialed in "Wits Reproductive Health and HIV Institute" in a lesser frequency.

Most popular intervention types in "Wits Reproductive Health and HIV Institute" are "Drug" (4 trials), "Other" (3 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Truvada" (2 trials), "10-1074-LS-J" (1 trials), "2-way SMS" (1 trials) and "3BNC117-LS-J" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wits Reproductive Health and HIV Institute" are 6 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Wits Reproductive Health and HIV Institute". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Wits Reproductive Health and HIV Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wits Reproductive Health and HIV Institute, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".